Rusnano Backs Three US Pharma Companies
Russian state technology firm Rusnano, alongside a group of investors, is investing $93 million in three U.S.-based pharmaceutical firms to develop drugs to treat illnesses such as epilepsy, Reuters reported Wednesday. Rusnano is making the investment with U.S. venture capital fund Domain Associates and other investors. Rusnano partnered with Domain in March with plans to invest around $760 million in U.S. healthcare and parmaceutical firms to bring new drugs to the Russian market.
19 December 2012•1 min read
